Parabilis Medicines, Inc. — Form 8-K
Filed September 2, 2026 · analyzed by the 8-K Agent
8-K
— Neutral
significance 18/100
What the filing says
Form 8-K Item 5.02 filing dated 2026-09-02 reports compensatory arrangements for certain officers and/or departure/election of directors. The filing references compensatory arrangements but does not provide specific dollar amounts, percentages, share counts, or names of affected parties in the accessible text. No concrete transaction details are disclosed in the extract provided.
Why this rating
Routine 8-K disclosure of officer compensation or director changes; no specific material amounts or transactions disclosed in available text; standard governance filing.
Extracted items
See more from September 2, 2026.
EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.